Hannah Joseph Hospital Ltd Share Price

₹80.00 2.50 (3.23%) BSE
as updated on 10-Apr-2026 16:59 | Sector - Healthcare

Day Range

  • Day's Low:80.00
  • Day's High:80.00

  • 52 Week Low55.99
  • 52 Week High88.80

Hannah Joseph Hospital Ltd's key Fundamentals

Market Cap ₹182 Cr.
P/E Ratio 25.2
TTM EPS 3.2
P/B Ratio 2.00
ROE 14.77
Debt to Equity 0.69
Face Value 10
BVPS 40.1
3 Year Sales Growth 10.09%

Hannah Joseph Hospital Ltd's Share Price Returns

1 Day 3.23%
1 Week 5.70%
1 Month 38.20%
3 Months 0.00%
6 Months 0.00%
1 Years 0.00%
3 Years 0.00%
5 Years 0.00%
10 Years 0%

Financial Ratio Analysis

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

Check our DeciZen before investing

Check Stock Quality
Check Stock Valuation
Check Price Trend

Hannah Joseph Hospital Ltd Shareholding Pattern

Promoters

(71.28%)

Institutions

(9.61%)

Non-Institutions

(19.11%)

Pledged shares as % of Promoter's holding (%)

(0.00%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Balance Sheet

(All Figures are in Crores.)

Profit And Loss

(All Figures in Cr. Adjusted EPS in Rs.)

Cash Flow

(All Figures are in Crores.)

About Hannah Joseph Hospital Ltd

Hannah Joseph Hospital was incorporated as ‘Hannah Joseph Hospital Private Limited’ at Tamil Nadu as a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated October 24, 2011, issued by the Registrar of Companies (ROC), Tamil Nadu, Chennai, Andaman and Nicobar Islands. Subsequently, the company was converted to a public limited company and the name of the company changed to ‘Hannah Joseph Hospital Limited’ on July 29, 2022.

The company is a multi-speciality healthcare provider, strategically located in Madurai, operating in a two acres campus, centrally air-conditioned hospital with central water heating system. It is a growing organization that aims at strengthening and establishing its presence in healthcare services providers. It strives to serve with its ultra-modern medical practices and state of the art infrastructure for medical as well as surgical care solutions. It has been consistently registering phenomenal growth in terms of complicated surgeries, patient volume and turnover making the hospital a landmark for neurosciences in the city of Madurai & South Tamil Nadu. Its medical facility encompasses full-fledged department of neuroradiology by meeting standards of Neurological Institute of International Standard. The company has also added the department of cardiac sciences with a Cath lab and cardiac operation theatres. The company also performs complex coronary angioplasties and open-heart Surgeries.

It was assessed and found to comply with NABH Accreditation Standards for Hospital 5th edition and has been awarded with a Certificate of Accreditation from National Accreditation Board for Hospitals and Healthcare Provider. Further, it has also received NABL 128 Certification from National Accreditation Board for Testing and Calibration Laboratories.  Its primary focus is Neurology, Cardiology, Psychiatry and Trauma healthcare where it has an understanding of global nuances, customer culture and the mindset of medical professionals and where there is a significant need for quality and affordable healthcare services.

Business area of the company

The company is renowned for its comprehensive and specialized medical care in Neurosciences, Cardiac Sciences, Orthopaedics, and Traumatology. Catering predominantly to the population of Central and South Tamil Nadu, the hospital stands out for its advanced medical services, commitment to patient care, and cutting-edge technologies. 

Services of the company

  • Neurosurgery
  • Neurology
  • Cardiology
  • Orthopaedics
  • Oral & Maxillofacial Surgery
  • Psychiatry
  • Radiology Services
  • Intensive Care Unit (ICU)
  • Intensive Cardiac Care Unit (ICCU)
  • Pathology Services

Awards and recognitions of the company

  • 2021: Excellence in Quality Awards to the Best Entry Level NABH Certified Neurology Specialty Hospital from the Tamil Nadu Government and FICCI.
  • 2023: Excellence in Neuroscience and Trauma Care award presented by the Times Business Awards
  • 2023: Ranked 1st in the Madurai city and among top 20 for Neuroscience in the South India comprising of 5 states and 2 union territories, as per the National Survey conducted by the Times of India
  • 2024: Neurosurgery Excellence Award for expertise in Innovation & Complex Neurosurgical Procedures from News18
  • 2025: Times Award 2025 (Madurai & Trichy regions) for Excellence in Neurosurgery & Interventional Neuroradiology in 2025.
  • 2025: Ranked No. 2 in India in the Best Neurosurgery Hospitals category by Outlook in association with NEB Research, published on June 2025.
  • 2025: Healthcare Excellence Award in Neurology (Above 100 Beds) Conferred on October 11, 2025 by the Confederation of Indian Industry (CII), Tamil Nadu during the MedClave 2025 event.
  • 2025: AHPI-TN Excellence Awards 2025, awarded by the AHPI Tamil Nadu Chapter on November 08, 2025.

History and milestones

  • 2011: Incorporation of the company as Hannah Joseph Hospital Private Limited
  • 2015: Intra Operative Neuro Monitoring was introduced
  • 2016: A complex high-risk surgery was performed with global fusion done at the brain spine junction on a young boy in 2 phases
  • 2017: Brain Lab Navigation was introduced
  • 2018: A brain tumour was removed using local anaesthesia and brain mapping with the patient fully conscious
  • 2020: The Hospital was shifted to its new campus which is spread over an area of 2 Acres with 150 Beds
  • 2021: The Neuro-endovascular Intervention for a Brain Aneurysm using ‘Silk Vista’ was performed
  • 2022: Conversion of Private Limited to Public Limited - Hannah Joseph Hospital Limited
  • 2022: Successfully performed the Sapien 3 Trans Catheter Heart Valve Implantation using Edwards Delivery System
  • 2022: A rare and complex Giant tumour was successfully removed from the CV junction (Brain/Spine junction) in a paediatric patient
  • 2022: The Interventional Neuroradiology team launched the advanced Intrasaccular Web Device (ISD) for the Endovascular treatment of Aneurysm patient
  • 2023: Hannah Joseph hospital has been Fully Accredited in NABH National Accreditation Board for Hospitals & Healthcare Providers (5th Edition) and NABL (National Accreditation Board for Hospitals & Healthcare Providers)
  • 2023: The Institute started six years Direct Dr NB Neurosurgery courses for post MBBS graduates offering 2 seats every year. 
  • 2023: A rare case of the Temporomandibular Joint Replacement Surgery was done by the Department of Oral Maxillofacial Surgery
  • 2024: Brain lab Fiber tracking Navigation 3.0 version for removing brain tumours has been launched
  • 2025: Performed a life- saving neuroendovascular procedure on a nine month old baby boy, diagnosed with a complex brain aneurysmal rupture, using ballon- assisted coils in the brain
  • 2025: Acquired land for Construction of Radiation Oncology Centre

Read More Read Less
Read More Read Less

Investment related blogs

Day Range

  • Day's Low: 80.00
  • Day's High: 80.00

  • 52 Week Low55.99
  • 52 Week High88.80

Hannah Joseph Hospital Ltd's key Fundamentals

Market Cap ₹182 Cr.
P/E Ratio 25.2
TTM EPS 3.2
P/B Ratio 2.00
ROE 14.77
Debt to Equity 0.69
Face Value 10
BVPS 40.1
3 Year Sales Growth 10.09%

Hannah Joseph Hospital Ltd's Share Price Returns

1 Day 3.23%
1 Week 5.70%
1 Month 38.20%
3 Months 0.00%
6 Months 0.00%
1 Years 0.00%
3 Years 0.00%
5 Years 0.00%
10 Years 0%

Investment related blogs

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×